Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
11/2006
11/02/2006CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/01/2006CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/31/2006US7129241 Pyridazine derivatives
10/31/2006CA2350560C Novel type condensed pyridazinone compounds
10/31/2006CA2276455C Phthalazinones
10/31/2006CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/26/2006WO2006113650A1 Design and synthesis of novel tubulin polymerization inhibitors: bonzoylphenyluria (bpu) sulfur analogs
10/26/2006WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006WO2006065448A3 Topoisomerase inhibitors and prodrugs
10/26/2006US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/26/2006CA2606174A1 Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs
10/25/2006EP1714654A1 Drug for inhibiting vascular intimal hyperplasia
10/25/2006EP1713784A1 Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
10/25/2006EP1713484A2 Compounds and methods of use
10/24/2006US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006CA2261848C Cell adhesion inhibitors
10/24/2006CA2223094C Phenylpyridazinones
10/24/2006CA2168023C Vasoconstrictive substituted aryloxyalkyl diamines
10/19/2006WO2006109817A1 1,4-substituted piperazine derivative
10/19/2006WO2006108714A2 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics
10/19/2006WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/19/2006US20060235021 Phenylpyridazine derivatives as ligands for gaba receptors
10/19/2006US20060235014 Inhibitors of p38
10/19/2006CA2603701A1 1,4-substituted piperazine derivative
10/19/2006CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/18/2006CN1849309A Pyridyl derivatives and their use as therapeutic agents
10/17/2006US7122680 3-Substituted oxindole β3 agonsists
10/17/2006US7122662 Tricyclic compound having spiro union
10/17/2006US7122535 For treating pain in a warm-blooded animal; enzyme inhibitor on NO-synthase enzymes; STROKE, NEURODEGENERATIVE DISEASES, ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS
10/17/2006CA2275686C Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
10/12/2006WO2006108107A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
10/12/2006US20060229363 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
10/12/2006CA2603250A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
10/11/2006CN1279026C Prostaglandin endoperoxide H synthase biosynthesis inhibitors
10/10/2006US7119091 Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient
10/05/2006WO2006104172A1 Preventive and/or therapeutic agent for rheumatoid arthritis
10/04/2006EP1706392A2 Pesticidal heterocyclic dihaloallyl compounds
10/04/2006EP1706387A1 Substituted heterocyclic amides having a fungicidal effect
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006US7115769 Catalyzing the alkylation, forming a 2-alkylcysteine derivatives, a chemical intermediates for iron chelating agents
10/03/2006US7115646 Cyclic diamines and derivatives as factor Xa inhibitors
10/03/2006US7115611 Phenyl derivatives, their manufacture and use as pharmaceutical agents
10/03/2006US7115600 Histamine-3 receptor modulators
10/03/2006US7115591 Pyridazinone compounds as cyclooxygenase [COX] 2 inhibitorsfor gastrointestinal disorders
09/2006
09/28/2006WO2006101058A1 Method for producing 3,6-dichloropyridazine-1-oxide
09/28/2006WO2006100100A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
09/28/2006WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
09/28/2006US20060217561 Synthesis of substituted thiazoline carboxylic acids
09/28/2006US20060217384 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder
09/28/2006US20060217372 Diaryl ethers as opioid receptor antagonist
09/28/2006DE102005014089A1 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories
09/28/2006CA2601789A1 Process for preparing 3,6-dichloropyridazine-1-oxide
09/28/2006CA2598205A1 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
09/28/2006CA2580857A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
09/21/2006WO2006097176A1 Phthalazinones
09/21/2006US20060211677 5-lipoxygenase activating protein inhibitors; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents
09/21/2006DE102005011822A1 Phthalazinone Phthalazinones
09/21/2006CA2600985A1 1-subsituted-3,4-dihydro-pthalazin-4-ones as eg5 inhibitors
09/20/2006CN1275947C Nitrogen-contg. heterocyclic carboxamide derivatives or salt thereof
09/19/2006US7109243 Inhibitors of cathepsin S
09/19/2006CA2232195C Isoxazolidine derivatives
09/14/2006WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/14/2006US20060205732 Nonphytotoxic; 4-Bromo-3-methoxy-N-4-[4(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide; 4-[(Allyloxycarbonyl)amino]-3-methoxy-N-4-[4-(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide
09/14/2006US20060205713 Antidiabetic agents; disease of glucose tolerance; insulin resistance; obesity; dyslipidemia; metabolic disorders; liver disorders; [4-(6-Phenethyloxy-pyridazin-3-yl)piperazin-1-yl]-(2-trifluoromethyl-phenyl)-methanone; stearoyl-CoA desaturase modulators
09/14/2006US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors
09/13/2006EP0917462B1 Cell adhesion inhibitors
09/13/2006CN1274670C Diaminopropionic acid derivatives
09/12/2006US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
09/08/2006WO2006094187A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
09/08/2006WO2006094034A1 Cinnoline compounds and their use as liver x receptor modilators
09/08/2006CA2599688A1 Cinnoline compounds and their use as liver x receptor modulators
09/07/2006US20060199826 Cyclopropane compounds and pharmaceutical use thereof
09/06/2006CN1829701A Piperazine derivatives and their use as therapeutic agents
09/06/2006CN1829699A Pyridazinyl- piperazines and their use as histamine h3 receptor
09/06/2006CN1829698A Pyridazine derivatives and their use as therapeutic agents
09/05/2006US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor
08/2006
08/31/2006WO2006091592A1 Naphthalene derivatives as modulators of the glucocorticoid receptor
08/31/2006WO2006090235A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
08/31/2006WO2006074223A3 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
08/31/2006US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma
08/31/2006US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands
08/31/2006CA2598518A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
08/30/2006EP1695705A1 Compounds effecting glucokinase
08/30/2006EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof
08/30/2006CN1826321A Quinolone derivative or its salt
08/30/2006CN1272415C Alkyl succinite hydrazide additive for lubricant
08/30/2006CN1272326C Phenylpyridazine derivatives and drugs containing the same
08/30/2006CN1272324C Novel herbicides
08/29/2006US7098211 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
08/24/2006WO2006078891A3 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives
08/24/2006US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
08/24/2006US20060189622 Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations
08/24/2006US20060189613 Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4)
08/23/2006EP1027328B1 Substituted anilides
08/23/2006CN1821230A Method for synthesizing 3-nitro or 3-amino phthalyl hydrazine
08/17/2006WO2006086447A2 Pyridazine derivatives and their use as therapeutic agents
08/17/2006WO2006060122A9 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
08/16/2006EP1689715A1 Tubulin inhibitors
08/16/2006EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof
08/16/2006EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 85